エルビテグラビル/コビシスタット/エムトリシタビン/テノホビルアラフェンアミド併用薬の世界市場予測 2019年：メーカー別、地域別、種類・用途別（～2024）

• 英文タイトル：Global Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

• レポートコード：B-GIR08C2063 • 出版社/出版日：GlobalInfoResearch / 2019年8月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、118ページ • 納品方法：Eメール • 産業分類：Pharma & Healthcare

• 販売価格（消費税別）

Single User	￥522,000 (USD3,480)	▷ お問い合わせ
Corporate User	￥1,044,000 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

本調査レポートは、エルビテグラビル/コビシスタット/エムトリシタビン/テノホビルアラフェンアミド併用薬の世界市場について調べ、まとめました。種類別セグメントは、1本/箱、3本/箱等、用途別セグメントは、メディア、コミュニケーション、医療等に区分しました。エルビテグラビル/コビシスタット/エムトリシタビン/テノホビルアラフェンアミド併用薬の世界市場概観、企業動向、企業別エルビテグラビル/コビシスタット/エムトリシタビン/テノホビルアラフェンアミド併用薬シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・エルビテグラビル/コビシスタット/エムトリシタビン/テノホビルアラフェンアミド併用薬の市場概観 ・エルビテグラビル/コビシスタット/エムトリシタビン/テノホビルアラフェンアミド併用薬の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・エルビテグラビル/コビシスタット/エムトリシタビン/テノホビルアラフェンアミド併用薬の企業別販売動向、市場シェア、市場集中度、競争動向 ・エルビテグラビル/コビシスタット/エムトリシタビン/テノホビルアラフェンアミド併用薬の世界市場規模 ・エルビテグラビル/コビシスタット/エムトリシタビン/テノホビルアラフェンアミド併用薬の北米市場分析（アメリカ、カナダ、メキシコ等） ・エルビテグラビル/コビシスタット/エムトリシタビン/テノホビルアラフェンアミド併用薬のアメリカ市場規模推移 ・エルビテグラビル/コビシスタット/エムトリシタビン/テノホビルアラフェンアミド併用薬のカナダ市場規模推移 ・エルビテグラビル/コビシスタット/エムトリシタビン/テノホビルアラフェンアミド併用薬のメキシコ市場規模推移 ・エルビテグラビル/コビシスタット/エムトリシタビン/テノホビルアラフェンアミド併用薬のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等） ・エルビテグラビル/コビシスタット/エムトリシタビン/テノホビルアラフェンアミド併用薬のドイツ市場規模推移 ・エルビテグラビル/コビシスタット/エムトリシタビン/テノホビルアラフェンアミド併用薬のイギリス市場規模推移 ・エルビテグラビル/コビシスタット/エムトリシタビン/テノホビルアラフェンアミド併用薬のロシア市場規模推移 ・エルビテグラビル/コビシスタット/エムトリシタビン/テノホビルアラフェンアミド併用薬のアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等） ・エルビテグラビル/コビシスタット/エムトリシタビン/テノホビルアラフェンアミド併用薬の日本市場規模推移 ・エルビテグラビル/コビシスタット/エムトリシタビン/テノホビルアラフェンアミド併用薬の中国市場規模推移 ・エルビテグラビル/コビシスタット/エムトリシタビン/テノホビルアラフェンアミド併用薬の韓国市場規模推移 ・エルビテグラビル/コビシスタット/エムトリシタビン/テノホビルアラフェンアミド併用薬のインド市場規模推移 ・エルビテグラビル/コビシスタット/エムトリシタビン/テノホビルアラフェンアミド併用薬の東南アジア市場規模推移 ・エルビテグラビル/コビシスタット/エムトリシタビン/テノホビルアラフェンアミド併用薬の南米市場分析（ブラジル、アルゼンチン等） ・エルビテグラビル/コビシスタット/エムトリシタビン/テノホビルアラフェンアミド併用薬の中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等） ・エルビテグラビル/コビシスタット/エムトリシタビン/テノホビルアラフェンアミド併用薬の種類別分析/販売量、売上、市場シェア（1本/箱、3本/箱） ・エルビテグラビル/コビシスタット/エムトリシタビン/テノホビルアラフェンアミド併用薬の用途別分析/市場規模（メディア、コミュニケーション、医療） ・エルビテグラビル/コビシスタット/エムトリシタビン/テノホビルアラフェンアミド併用薬の市場予測2019年-2024年（地域別予測、種類別予測、用途別予測） ・エルビテグラビル/コビシスタット/エムトリシタビン/テノホビルアラフェンアミド併用薬の販売チャネル・代理店・貿易業者・ディーラー分析

Scope of the Report:
The worldwide market for Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers
Gilead Sciences
Biocon Limited
Flamingo Pharmaceuticals Limited
IPCA Laboratories
Medisist Pharma
Affine Formulations Limited

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
1 Bottle/Box
3 Bottles/Box

Market Segment by Applications, can be divided into
Hospital
Clinic
Drug Center
Other

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug, with price, sales, revenue and global market share of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug in 2017 and 2018.
Chapter 3, the Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug sales channel, distributors, customers, research findings and conclusion, appendix and data source.

レポート目次

---

Table of Contents

1 Market Overview
1.1 Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Introduction
1.2 Market Analysis by Type
1.2.1 1 Bottle/Box
1.2.2 3 Bottles/Box
1.3 Market Analysis by Applications
1.3.1 Hospital
1.3.2 Clinic
1.3.3 Drug Center
1.3.4 Other
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2014-2024)
1.4.1.2 Canada Market States and Outlook (2014-2024)
1.4.1.3 Mexico Market States and Outlook (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2014-2024)
1.4.2.2 France Market States and Outlook (2014-2024)
1.4.2.3 UK Market States and Outlook (2014-2024)
1.4.2.4 Russia Market States and Outlook (2014-2024)
1.4.2.5 Italy Market States and Outlook (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2014-2024)
1.4.3.2 Japan Market States and Outlook (2014-2024)
1.4.3.3 Korea Market States and Outlook (2014-2024)
1.4.3.4 India Market States and Outlook (2014-2024)
1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2014-2024)
1.4.4.2 Egypt Market States and Outlook (2014-2024)
1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
1.4.4.4 South Africa Market States and Outlook (2014-2024)
1.4.4.5 Turkey Market States and Outlook (2014-2024)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Gilead Sciences
2.1.1 Business Overview
2.1.2 Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Gilead Sciences Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.2 Biocon Limited
2.2.1 Business Overview
2.2.2 Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Biocon Limited Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.3 Flamingo Pharmaceuticals Limited
2.3.1 Business Overview
2.3.2 Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Flamingo Pharmaceuticals Limited Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.4 IPCA Laboratories
2.4.1 Business Overview
2.4.2 Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 IPCA Laboratories Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.5 Medisist Pharma
2.5.1 Business Overview
2.5.2 Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Medisist Pharma Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.6 Affine Formulations Limited
2.6.1 Business Overview
2.6.2 Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Affine Formulations Limited Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
3 Global Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
3.1 Global Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Sales and Market Share by Manufacturer (2017-2018)
3.2 Global Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Revenue and Market Share by Manufacturer (2017-2018)
3.3 Market Concentration Rate
3.3.1 Top 3 Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Manufacturer Market Share in 2018
3.3.2 Top 6 Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Manufacturer Market Share in 2018
3.4 Market Competition Trend
4 Global Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Market Analysis by Regions
4.1 Global Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Sales, Revenue and Market Share by Regions
4.1.1 Global Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Sales and Market Share by Regions (2014-2019)
4.1.2 Global Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Revenue and Market Share by Regions (2014-2019)
4.2 North America Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Sales and Growth Rate (2014-2019)
4.3 Europe Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Sales and Growth Rate (2014-2019)
4.4 Asia-Pacific Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Sales and Growth Rate (2014-2019)
4.5 South America Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Sales and Growth Rate (2014-2019)
4.6 Middle East and Africa Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Sales and Growth Rate (2014-2019)
5 North America Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug by Country
5.1 North America Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Sales, Revenue and Market Share by Country
5.1.1 North America Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Sales and Market Share by Country (2014-2019)
5.1.2 North America Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Revenue and Market Share by Country (2014-2019)
5.2 United States Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Sales and Growth Rate (2014-2019)
5.3 Canada Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Sales and Growth Rate (2014-2019)
5.4 Mexico Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Sales and Growth Rate (2014-2019)
6 Europe Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug by Country
6.1 Europe Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Sales, Revenue and Market Share by Country
6.1.1 Europe Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Sales and Market Share by Country (2014-2019)
6.1.2 Europe Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Revenue and Market Share by Country (2014-2019)
6.2 Germany Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Sales and Growth Rate (2014-2019)
6.3 UK Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Sales and Growth Rate (2014-2019)
6.4 France Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Sales and Growth Rate (2014-2019)
6.5 Russia Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Sales and Growth Rate (2014-2019)
6.6 Italy Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Sales and Growth Rate (2014-2019)
7 Asia-Pacific Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug by Country
7.1 Asia-Pacific Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Sales, Revenue and Market Share by Country
7.1.1 Asia-Pacific Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Sales and Market Share by Country (2014-2019)
7.1.2 Asia-Pacific Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Revenue and Market Share by Country (2014-2019)
7.2 China Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Sales and Growth Rate (2014-2019)
7.3 Japan Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Sales and Growth Rate (2014-2019)
7.4 Korea Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Sales and Growth Rate (2014-2019)
7.5 India Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Sales and Growth Rate (2014-2019)
7.6 Southeast Asia Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Sales and Growth Rate (2014-2019)
8 South America Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug by Country
8.1 South America Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Sales, Revenue and Market Share by Country
8.1.1 South America Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Sales and Market Share by Country (2014-2019)
8.1.2 South America Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Revenue and Market Share by Country (2014-2019)
8.2 Brazil Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Sales and Growth Rate (2014-2019)
8.3 Argentina Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Sales and Growth Rate (2014-2019)
8.4 Colombia Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Sales and Growth Rate (2014-2019)
9 Middle East and Africa Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug by Countries
9.1 Middle East and Africa Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Sales, Revenue and Market Share by Country
9.1.1 Middle East and Africa Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Sales and Market Share by Country (2014-2019)
9.1.2 Middle East and Africa Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Revenue and Market Share by Country (2014-2019)
9.2 Saudi Arabia Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Sales and Growth Rate (2014-2019)
9.3 Turkey Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Sales and Growth Rate (2014-2019)
9.4 Egypt Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Sales and Growth Rate (2014-2019)
9.5 Nigeria Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Sales and Growth Rate (2014-2019)
9.6 South Africa Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Sales and Growth Rate (2014-2019)
10 Global Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Market Segment by Type
10.1 Global Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Sales, Revenue and Market Share by Type (2014-2019)
10.1.1 Global Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Sales and Market Share by Type (2014-2019)
10.1.2 Global Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Revenue and Market Share by Type (2014-2019)
10.2 1 Bottle/Box Sales Growth and Price
10.2.1 Global 1 Bottle/Box Sales Growth (2014-2019)
10.2.2 Global 1 Bottle/Box Price (2014-2019)
10.3 3 Bottles/Box Sales Growth and Price
10.3.1 Global 3 Bottles/Box Sales Growth (2014-2019)
10.3.2 Global 3 Bottles/Box Price (2014-2019)
11 Global Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Market Segment by Application
11.1 Global Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Sales Market Share by Application (2014-2019)
11.2 Hospital Sales Growth (2014-2019)
11.3 Clinic Sales Growth (2014-2019)
11.4 Drug Center Sales Growth (2014-2019)
11.5 Other Sales Growth (2014-2019)
12 Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Market Forecast (2019-2024)
12.1 Global Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Sales, Revenue and Growth Rate (2019-2024)
12.2 Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Market Forecast by Regions (2019-2024)
12.2.1 North America Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Market Forecast (2019-2024)
12.2.2 Europe Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Market Forecast (2019-2024)
12.2.3 Asia-Pacific Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Market Forecast (2019-2024)
12.2.4 South America Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Market Forecast (2019-2024)
12.2.5 Middle East and Africa Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Market Forecast (2019-2024)
12.3 Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Market Forecast by Type (2019-2024)
12.3.1 Global Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Sales Forecast by Type (2019-2024)
12.3.2 Global Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Market Share Forecast by Type (2019-2024)
12.4 Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Market Forecast by Application (2019-2024)
12.4.1 Global Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Sales Forecast by Application (2019-2024)
12.4.2 Global Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Market Share Forecast by Application (2019-2024)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source

List of Tables and Figures

Figure Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Picture
Table Product Specifications of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug
Figure Global Sales Market Share of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug by Types in 2018
Table Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Types for Major Manufacturers
Figure 1 Bottle/Box Picture
Figure 3 Bottles/Box Picture
Figure Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Sales Market Share by Applications in 2018
Figure Hospital Picture
Figure Clinic Picture
Figure Drug Center Picture
Figure Other Picture
Figure United States Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Revenue (Value) and Growth Rate (2014-2024)
Figure Canada Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Revenue (Value) and Growth Rate (2014-2024)
Figure Mexico Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Revenue (Value) and Growth Rate (2014-2024)
Figure Germany Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Revenue (Value) and Growth Rate (2014-2024)
Figure France Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Revenue (Value) and Growth Rate (2014-2024)
Figure UK Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Revenue (Value) and Growth Rate (2014-2024)
Figure Russia Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Revenue (Value) and Growth Rate (2014-2024)
Figure Italy Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Revenue (Value) and Growth Rate (2014-2024)
Figure China Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Revenue (Value) and Growth Rate (2014-2024)
Figure Japan Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Revenue (Value) and Growth Rate (2014-2024)
Figure Korea Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Revenue (Value) and Growth Rate (2014-2024)
Figure India Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Revenue (Value) and Growth Rate (2014-2024)
Figure Southeast Asia Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Revenue (Value) and Growth Rate (2014-2024)
Figure Brazil Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Revenue (Value) and Growth Rate (2014-2024)
Figure Egypt Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Revenue (Value) and Growth Rate (2014-2024)
Figure Saudi Arabia Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Revenue (Value) and Growth Rate (2014-2024)
Figure South Africa Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Revenue (Value) and Growth Rate (2014-2024)
Figure Nigeria Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Revenue (Value) and Growth Rate (2014-2024)
Table Gilead Sciences Basic Information, Manufacturing Base and Competitors
Table Gilead Sciences Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Type and Applications
Table Gilead Sciences Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Biocon Limited Basic Information, Manufacturing Base and Competitors
Table Biocon Limited Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Type and Applications
Table Biocon Limited Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Flamingo Pharmaceuticals Limited Basic Information, Manufacturing Base and Competitors
Table Flamingo Pharmaceuticals Limited Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Type and Applications
Table Flamingo Pharmaceuticals Limited Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table IPCA Laboratories Basic Information, Manufacturing Base and Competitors
Table IPCA Laboratories Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Type and Applications
Table IPCA Laboratories Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Medisist Pharma Basic Information, Manufacturing Base and Competitors
Table Medisist Pharma Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Type and Applications
Table Medisist Pharma Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Affine Formulations Limited Basic Information, Manufacturing Base and Competitors
Table Affine Formulations Limited Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Type and Applications
Table Affine Formulations Limited Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Global Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Sales by Manufacturer (2017-2018)
Figure Global Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Sales Market Share by Manufacturer in 2017
Figure Global Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Sales Market Share by Manufacturer in 2018
Table Global Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Revenue by Manufacturer (2017-2018)
Figure Global Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Revenue Market Share by Manufacturer in 2017
Figure Global Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Revenue Market Share by Manufacturer in 2018
Figure Top 3 Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Manufacturer (Revenue) Market Share in 2018
Figure Top 6 Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Manufacturer (Revenue) Market Share in 2018
Figure Global Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Sales and Growth Rate (2014-2019)
Figure Global Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Revenue and Growth Rate (2014-2019)
Table Global Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Sales by Regions (2014-2019)
Table Global Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Sales Market Share by Regions (2014-2019)
Table Global Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Revenue by Regions (2014-2019)
Figure Global Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Revenue Market Share by Regions (2014-2019)
Figure Global Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Revenue Market Share by Regions in 2018
Figure North America Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Sales and Growth Rate (2014-2019)
Figure Europe Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Sales and Growth Rate (2014-2019)
Figure Asia-Pacific Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Sales and Growth Rate (2014-2019)
Figure South America Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Sales and Growth Rate (2014-2019)
Figure Middle East and Africa Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Sales and Growth Rate (2014-2019)
Figure North America Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Revenue and Growth Rate (2014-2019)
Table North America Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Sales by Countries (2014-2019)
Table North America Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Sales Market Share by Countries (2014-2019)
Figure North America Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Sales Market Share by Countries (2014-2019)
Figure North America Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Sales Market Share by Countries in 2018
Table North America Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Revenue by Countries (2014-2019)
Table North America Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Revenue Market Share by Countries (2014-2019)
Figure North America Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Revenue Market Share by Countries (2014-2019)
Figure North America Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Revenue Market Share by Countries in 2018
Figure United States Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Sales and Growth Rate (2014-2019)
Figure Canada Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Sales and Growth Rate (2014-2019)
Figure Mexico Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Sales and Growth Rate (2014-2019)
Figure Europe Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Revenue and Growth Rate (2014-2019)
Table Europe Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Sales by Countries (2014-2019)
Table Europe Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Sales Market Share by Countries (2014-2019)
Table Europe Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Revenue by Countries (2014-2019)
Figure Europe Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Revenue Market Share by Countries (2014-2019)
Figure Europe Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Revenue Market Share by Countries in 2018
Figure Germany Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Sales and Growth Rate (2014-2019)
Figure UK Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Sales and Growth Rate (2014-2019)
Figure France Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Sales and Growth Rate (2014-2019)
Figure Russia Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Sales and Growth Rate (2014-2019)
Figure Italy Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Sales and Growth Rate (2014-2019)
Figure Asia-Pacific Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Sales by Countries (2014-2019)
Table Asia-Pacific Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Sales Market Share by Countries (2014-2019)
Figure Asia-Pacific Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Sales Market Share by Countries 2018
Table Asia-Pacific Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Revenue by Countries (2014-2019)
Figure Asia-Pacific Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Revenue Market Share by Countries 2018
Figure China Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Sales and Growth Rate (2014-2019)
Figure Japan Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Sales and Growth Rate (2014-2019)
Figure Korea Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Sales and Growth Rate (2014-2019)
Figure India Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Sales and Growth Rate (2014-2019)
Figure Southeast Asia Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Sales and Growth Rate (2014-2019)
Figure South America Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Revenue and Growth Rate (2014-2019)
Table South America Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Sales by Countries (2014-2019)
Table South America Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Sales Market Share by Countries (2014-2019)
Figure South America Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Sales Market Share by Countries in 2018
Table South America Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Revenue by Countries (2014-2019)
Table South America Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Revenue Market Share by Countries (2014-2019)
Figure South America Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Revenue Market Share by Countries in 2018
Figure Brazil Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Sales and Growth Rate (2014-2019)
Figure Argentina Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Sales and Growth Rate (2014-2019)
Figure Colombia Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Sales and Growth Rate (2014-2019)
Figure Middle East and Africa Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Sales by Countries (2014-2019)
Table Middle East and Africa Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Sales Market Share by Countries (2014-2019)
Figure Middle East and Africa Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Sales Market Share by Countries in 2018
Table Middle East and Africa Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Revenue by Countries (2014-2019)
Table Middle East and Africa Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Revenue Market Share by Countries in 2018
Figure Saudi Arabia Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Sales and Growth Rate (2014-2019)
Figure UAE Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Sales and Growth Rate (2014-2019)
Figure Egypt Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Sales and Growth Rate (2014-2019)
Figure Nigeria Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Sales and Growth Rate (2014-2019)
Figure South Africa Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Sales and Growth Rate (2014-2019)
Table Global Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Sales by Type (2014-2019)
Table Global Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Sales Share by Type (2014-2019)
Table Global Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Revenue by Type (2014-2019)
Table Global Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Revenue Share by Type (2014-2019)
Figure Global 1 Bottle/Box Sales Growth (2014-2019)
Figure Global 1 Bottle/Box Price (2014-2019)
Figure Global 3 Bottles/Box Sales Growth (2014-2019)
Figure Global 3 Bottles/Box Price (2014-2019)
Table Global Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Sales by Application (2014-2019)
Table Global Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Sales Share by Application (2014-2019)
Figure Global Clinic Sales Growth (2014-2019)
Figure Global Drug Center Sales Growth (2014-2019)
Figure Global Other Sales Growth (2014-2019)
Figure Global Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Sales, Revenue and Growth Rate (2019-2024)
Table Global Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Sales Forecast by Regions (2019-2024)
Table Global Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Market Share Forecast by Regions (2019-2024)
Figure North America Sales Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Market Forecast (2019-2024)
Figure Europe Sales Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Market Forecast (2019-2024)
Figure Asia-Pacific Sales Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Market Forecast (2019-2024)
Figure South America Sales Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Market Forecast (2019-2024)
Figure Middle East and Africa Sales Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Market Forecast (2019-2024)
Table Global Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Sales Forecast by Type (2019-2024)
Table Global Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Market Share Forecast by Type (2019-2024)
Table Global Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Sales Forecast by Application (2019-2024)
Table Global Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Market Share Forecast by Application (2019-2024)
Table Distributors/Traders/ Dealers List

---